{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T20:11:50Z","timestamp":1793391110780,"version":"4.5.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T00:00:00Z","timestamp":1739145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T00:00:00Z","timestamp":1739145600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100030902","name":"Martin-Luther-Universit\u00e4t Halle-Wittenberg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100030902","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Backround<\/jats:title>\n                    <jats:p>Cardiac involvement has been reported in different mitochondrial geno- and phenotypes, including mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like (MELAS) syndrome. However, cardiac manifestations are diverse and not well described.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We prospectively examined cardiac manifestations in 11 adult patients with MELAS syndrome harboring the MTTL1 m.3243A\u2009&lt;\u2009G-mutation using patient records, cardiac MRI (1.5 Tesla), echocardiography, electrocardiogram (ECG), laboratory tests of cardiac markers (CK, CK-MB, Trop I, BNP), and clinical severity (NMDAS\u2009=\u2009Newcastle Mitochondrial Disease Scale).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 11 consecutive patients with MELAS syndrome (73% male, mean age 37.5\u2009\u00b1\u200910.6 years) cardiac manifestations were found in nine (82%). Pathology was mainly detected using MRI (9 of 11, 82%). Six patients showed diffuse late enhancement in the left ventricle, one a left ventricular ejection fraction (LVEF) below 30%, two with a LVEF in the range of 40\u201350% in the cardiac MRI, and another five patients presenting diastolic dysfunction as defined by echocardiography. Only one patient with late enhancement on MRI also showed a conduction block in the ECG. There was no correlation between the cardiac manifestations and the NMDAS score or heteroplasmy grade.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Cardiac involvement in MELAS syndrome harboring the MTTL1 m.3243A\u2009&gt;\u2009G mutation mostly entails cardiomyopathy, which was particularly evident in the cardiac MRI. Only one patient (1\/11, 9.1%) had conduction defects. Thus, cardiac testing including cardiac MRI, echocardiography and ECG seems to be important for prognosis of MELAS patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-025-03534-5","type":"journal-article","created":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T08:09:23Z","timestamp":1739174963000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Cardiac manifestations in adult MELAS syndrome (mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes syndrome)\u2013 a cross-sectional study"],"prefix":"10.1186","volume":"20","author":[{"given":"Dietrich","family":"Stoevesandt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Schlitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"R\u00f6ntgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6060-3810","authenticated-orcid":false,"given":"Torsten","family":"Kraya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,10]]},"reference":[{"issue":"44","key":"3534_CR1","first-page":"741","volume":"118","author":"T Klopstock","year":"2021","unstructured":"Klopstock T, Priglinger C, Yilmaz A, Kornblum C, Distelmaier F, Prokisch H. Mitochondrial disorders. Dtsch Arztebl Int. 2021;118(44):741\u20138.","journal-title":"Dtsch Arztebl Int"},{"issue":"Pt 10","key":"3534_CR2","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1093\/brain\/awh259","volume":"127","author":"M Zeviani","year":"2004","unstructured":"Zeviani M, Di Donato S. Mitochondrial disorders. Brain. 2004;127(Pt 10):2153\u201372.","journal-title":"Brain"},{"issue":"9529","key":"3534_CR3","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/S0140-6736(06)68970-8","volume":"368","author":"AHV Schapira","year":"2006","unstructured":"Schapira AHV. Mitochondrial disease. Lancet. 2006;368(9529):70\u201382.","journal-title":"Lancet"},{"issue":"1\u20132","key":"3534_CR4","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.ymgme.2015.06.004","volume":"116","author":"AW El-Hattab","year":"2015","unstructured":"El-Hattab AW, Adesina AM, Jones J, Scaglia F. MELAS syndrome: Clinical manifestations, pathogenesis, and treatment options. Mol Genet Metab. 2015;116(1\u20132):4\u201312.","journal-title":"Mol Genet Metab"},{"key":"3534_CR5","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1196\/annals.1444.011","volume":"1142","author":"DM Sproule","year":"2008","unstructured":"Sproule DM, Kaufmann P. Mitochondrial encephalopathy, lactic acidosis, and strokelike episodes: basic concepts, clinical phenotype, and therapeutic management of MELAS syndrome. Ann N Y Acad Sci. 2008;1142:133\u201358.","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"3534_CR6","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1177\/088307389400900102","volume":"9","author":"M Hirano","year":"1994","unstructured":"Hirano M, Pavlakis SG. Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes (MELAS): current concepts. J Child Neurol. 1994;9(1):4\u201313.","journal-title":"J Child Neurol"},{"issue":"4","key":"3534_CR7","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1002\/ana.410160409","volume":"16","author":"SG Pavlakis","year":"1984","unstructured":"Pavlakis SG, Phillips PC, DiMauro S, De Vivo DC, Rowland LP. Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: a distinctive clinical syndrome. Ann Neurol. 1984;16(4):481\u20138.","journal-title":"Ann Neurol"},{"issue":"2","key":"3534_CR8","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/0960-8966(92)90045-8","volume":"2","author":"M Hirano","year":"1992","unstructured":"Hirano M, Ricci E, Koenigsberger MR, Defendini R, Pavlakis SG, DeVivo DC, et al. Melas: an original case and clinical criteria for diagnosis. Neuromuscul Disord. 1992;2(2):125\u201335.","journal-title":"Neuromuscul Disord"},{"issue":"6","key":"3534_CR9","doi-asserted-by":"publisher","first-page":"e8262","DOI":"10.15252\/emmm.201708262","volume":"10","author":"JP Grady","year":"2018","unstructured":"Grady JP, Pickett SJ, Ng YS, Alston CL, Blakely EL, Hardy SA, McFarland R. mt DNA heteroplasmy level and copy number indicate disease burden in m 3243A> G mitochondrial disease. EMBO Mol Med. 2018;10(6):e8262.","journal-title":"EMBO Mol Med"},{"issue":"2016","key":"3534_CR10","first-page":"1490181","volume":"7","author":"S Seitun","year":"2016","unstructured":"Seitun S, Massobrio L, Rubegni A, Nesti C, Castiglione Morelli M, Boccalini S, et al. MELAS syndrome with cardiac involvement: a multimodality imaging approach. Case Rep Cardiol. 2016;7(2016):1490181.","journal-title":"Case Rep Cardiol"},{"issue":"276","key":"3534_CR11","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ijcard.2018.10.051","volume":"1","author":"A Brambilla","year":"2019","unstructured":"Brambilla A, Favilli S, Olivotto I, Calabri GB, Porcedda G, De Simone L, et al. Clinical profile and outcome of cardiac involvement in MELAS syndrome. Int J Cardiol. 2019;1(276):14\u20139.","journal-title":"Int J Cardiol"},{"issue":"4","key":"3534_CR12","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1007\/s00059-018-4739-6","volume":"45","author":"J Finsterer","year":"2020","unstructured":"Finsterer J, Zarrouk-Mahjoub S. The heart in m.3243A>G carriers. Herz. 2020;45(4):356\u201361.","journal-title":"Herz"},{"issue":"4","key":"3534_CR13","doi-asserted-by":"publisher","DOI":"10.1212\/NXG.0000000000000339","volume":"5","author":"A Quadir","year":"2019","unstructured":"Quadir A, Pontifex CS, Lee Robertson H, Labos C, Pfeffer G. Systematic review and meta-analysis of cardiac involvement in mitochondrial myopathy. Neurol Genet. 2019;5(4).","journal-title":"Neurol Genet"},{"issue":"1","key":"3534_CR14","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s10741-015-9524-5","volume":"21","author":"Y-HR Hsu","year":"2016","unstructured":"Hsu Y-HR, Yogasundaram H, Parajuli N, Valtuille L, Sergi C, Oudit GY. MELAS syndrome and cardiomyopathy: linking mitochondrial function to heart failure pathogenesis. Heart Fail Rev. 2016;21(1):103\u201316.","journal-title":"Heart Fail Rev"},{"issue":"1","key":"3534_CR15","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1161\/CIRCHEARTFAILURE.111.963900","volume":"5","author":"N Stalder","year":"2012","unstructured":"Stalder N, Yarol N, Tozzi P, Rotman S, Morris M, Fellmann F, et al. Mitochondrial A3243G mutation with manifestation of acute dilated cardiomyopathy. Circ Heart Fail. 2012;5(1):e1-3.","journal-title":"Circ Heart Fail"},{"issue":"2","key":"3534_CR16","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1471-2261-2-12","volume":"1","author":"K Majamaa-Voltti","year":"2002","unstructured":"Majamaa-Voltti K, Peuhkurinen K, Kortelainen M-L, Hassinen IE, Majamaa K. Cardiac abnormalities in patients with mitochondrial DNA mutation 3243A>G. BMC Cardiovasc Disord. 2002;1(2):12.","journal-title":"BMC Cardiovasc Disord"},{"issue":"2","key":"3534_CR17","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.amjcard.2006.07.089","volume":"99","author":"TCG Vydt","year":"2007","unstructured":"Vydt TCG, de Coo RFM, Soliman OII, Ten Cate FJ, van Geuns R-JM, Vletter WB, et al. Cardiac involvement in adults with m.3243A>G MELAS gene mutation. Am J Cardiol. 2007;99(2):264\u20139.","journal-title":"Am J Cardiol"},{"issue":"7","key":"3534_CR18","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.nmd.2012.03.001","volume":"22","author":"KG Hollingsworth","year":"2012","unstructured":"Hollingsworth KG, Gorman GS, Trenell MI, McFarland R, Taylor RW, Turnbull DM, et al. Cardiomyopathy is common in patients with the mitochondrial DNA m.3243A>G mutation and correlates with mutation load. Neuromuscul Disord. 2012;22(7):592\u20136.","journal-title":"Neuromuscul Disord"},{"key":"3534_CR19","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.mito.2017.12.012","volume":"44","author":"T Kraya","year":"2019","unstructured":"Kraya T, Neumann L, Paelecke-Habermann Y, Deschauer M, Stoevesandt D, Zierz S, Watzke S. Cognitive impairment, clinical severity and MRI changes in MELAS syndrome. Mitochondrion. 2019;44:53\u20137.","journal-title":"Mitochondrion"},{"issue":"12","key":"3534_CR20","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1212\/01.wnl.0000219759.72195.41","volume":"66","author":"AM Schaefer","year":"2006","unstructured":"Schaefer AM, Phoenix C, Elson JL, McFarland R, Chinnery PF, Turnbull DM. Mitochondrial disease in adults: a scale to monitor progression and treatment. Neurology. 2006;66(12):1932\u20134.","journal-title":"Neurology"},{"key":"3534_CR21","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s11789-009-0051-6","volume":"4","author":"T Buck","year":"2009","unstructured":"Buck T, Breithardt OA, Faber L, Fehske W, Flachskampf FA, Franke A, Nixdorff U. Manual zur indikation und durchf\u00fchrung der echokardiographie. Clin Res Cardiol Suppl. 2009;4:3\u201351.","journal-title":"Clin Res Cardiol Suppl"},{"issue":"2","key":"3534_CR22","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s00059-002-2351-1","volume":"27","author":"R Erbel","year":"2002","unstructured":"Erbel R, Neumann T, Zeidan Z, Bartel T, Buck T. Echocardiography diagnosis of diastolic heart failure. Herz. 2002;27(2):99\u2013106.","journal-title":"Herz"},{"issue":"27","key":"3534_CR23","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37(27):2129\u2013200.","journal-title":"Eur Heart J"},{"issue":"4","key":"3534_CR24","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s00392-011-0387-z","volume":"101","author":"A Yilmaz","year":"2012","unstructured":"Yilmaz A, Gdynia H-J, Ponfick M, R\u00f6sch S, Lindner A, Ludolph AC, et al. Cardiovascular magnetic resonance imaging (CMR) reveals characteristic pattern of myocardial damage in patients with mitochondrial myopathy. Clin Res Cardiol. 2012;101(4):255\u201361.","journal-title":"Clin Res Cardiol"},{"issue":"17","key":"3534_CR25","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12968-015-0145-x","volume":"22","author":"A Florian","year":"2015","unstructured":"Florian A, Ludwig A, Stubbe-Dr\u00e4ger B, Boentert M, Young P, Waltenberger J, et al. Characteristic cardiac phenotypes are detected by cardiovascular magnetic resonance in patients with different clinical phenotypes and genotypes of mitochondrial myopathy. J Cardiovasc Magn Reson. 2015;22(17):40.","journal-title":"J Cardiovasc Magn Reson"},{"issue":"3","key":"3534_CR26","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.ymgme.2022.05.004","volume":"136","author":"CLF Hendrix","year":"2022","unstructured":"Hendrix CLF, van den Heuvel FMA, Rodwell L, Timmermans J, Nijveldt R, Janssen MCH, et al. Screening and prevalence of cardiac abnormalities on electro- and echocardiography in a large cohort of patients with mitochondrial disease. Mol Genet Metab. 2022;136(3):219\u201325.","journal-title":"Mol Genet Metab"},{"issue":"5","key":"3534_CR27","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.bbagen.2011.03.015","volume":"1820","author":"S Yatsuga","year":"2012","unstructured":"Yatsuga S, Povalko N, Nishioka J, Katayama K, Kakimoto N, Matsuishi T, et al. MELAS: a nationwide prospective cohort study of 96 patients in Japan. Biochim Biophys Acta. 2012;1820(5):619\u201324.","journal-title":"Biochim Biophys Acta"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03534-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-03534-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03534-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T08:09:26Z","timestamp":1739174966000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-025-03534-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,10]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3534"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-03534-5","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,10]]},"assertion":[{"value":"4 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki, and approved by the Ethics Committee of Medical Faculty of Martin-Luther-University Halle Wittenberg, Halle\/Saale, Germany, 22.8.2007.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent was obtained from all subjects involved in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"62"}}